169 related articles for article (PubMed ID: 2973464)
21. Sequence of DNA flanking the exons of the HEXA gene, and identification of mutations in Tay-Sachs disease.
Triggs-Raine BL; Akerman BR; Clarke JT; Gravel RA
Am J Hum Genet; 1991 Nov; 49(5):1041-54. PubMed ID: 1833974
[TBL] [Abstract][Full Text] [Related]
22. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients.
Tanaka A; Ohno K; Sandhoff K; Maire I; Kolodny EH; Brown A; Suzuki K
Am J Hum Genet; 1990 Feb; 46(2):329-39. PubMed ID: 2137287
[TBL] [Abstract][Full Text] [Related]
23. Beta-hexosaminidase: biosynthesis and processing of the normal enzyme, and identification of mutations causing Jewish Tay-Sachs disease.
Mahuran DJ
Clin Biochem; 1995 Apr; 28(2):101-6. PubMed ID: 7628066
[TBL] [Abstract][Full Text] [Related]
24. Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments.
Akli S; Chelly J; Lacorte JM; Poenaru L; Kahn A
Genomics; 1991 Sep; 11(1):124-34. PubMed ID: 1837283
[TBL] [Abstract][Full Text] [Related]
25. Frequency of the Tay-Sachs disease splice and insertion mutations in the UK Ashkenazi Jewish population.
Landels EC; Ellis IH; Fensom AH; Green PM; Bobrow M
J Med Genet; 1991 Mar; 28(3):177-80. PubMed ID: 1828838
[TBL] [Abstract][Full Text] [Related]
26. [Tay-Sachs disease].
Tanaka A
Nihon Rinsho; 1993 Sep; 51(9):2281-5. PubMed ID: 8411703
[TBL] [Abstract][Full Text] [Related]
27. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.
Triggs-Raine BL; Mules EH; Kaback MM; Lim-Steele JS; Dowling CE; Akerman BR; Natowicz MR; Grebner EE; Navon R; Welch JP
Am J Hum Genet; 1992 Oct; 51(4):793-801. PubMed ID: 1384323
[TBL] [Abstract][Full Text] [Related]
28. Two new mutations in a late infantile Tay-Sachs patient are both in exon 1 of the beta-hexosaminidase alpha subunit gene.
Harmon DL; Gardner-Medwin D; Stirling JL
J Med Genet; 1993 Feb; 30(2):123-8. PubMed ID: 8445615
[TBL] [Abstract][Full Text] [Related]
29. Identification and rapid detection of three Tay-Sachs mutations in the Moroccan Jewish population.
Drucker L; Proia RL; Navon R
Am J Hum Genet; 1992 Aug; 51(2):371-7. PubMed ID: 1322637
[TBL] [Abstract][Full Text] [Related]
30. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
Myerowitz R
Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
[TBL] [Abstract][Full Text] [Related]
31. A novel mutation in the invariant AG of the acceptor splice site of intron 4 of the beta-hexosaminidase alpha-subunit gene in two unrelated American black GM2-gangliosidosis (Tay-Sachs disease) patients.
Mules EH; Dowling CE; Petersen MB; Kazazian HH; Thomas GH
Am J Hum Genet; 1991 Jun; 48(6):1181-5. PubMed ID: 1827945
[TBL] [Abstract][Full Text] [Related]
32. A deletion involving Alu sequences in the beta-hexosaminidase alpha-chain gene of French Canadians with Tay-Sachs disease.
Myerowitz R; Hogikyan ND
J Biol Chem; 1987 Nov; 262(32):15396-9. PubMed ID: 2824459
[TBL] [Abstract][Full Text] [Related]
33. Genetic cause of a juvenile form of Sandhoff disease. Abnormal splicing of beta-hexosaminidase beta chain gene transcript due to a point mutation within intron 12.
Nakano T; Suzuki K
J Biol Chem; 1989 Mar; 264(9):5155-8. PubMed ID: 2522450
[TBL] [Abstract][Full Text] [Related]
34. An unusual genotype in an Ashkenazi Jewish patient with Tay-Sachs disease.
Shore S; Tomczak J; Grebner EE; Myerowitz R
Hum Mutat; 1992; 1(6):486-90. PubMed ID: 1301958
[TBL] [Abstract][Full Text] [Related]
35. Beta-hexosaminidase splice site mutation has a high frequency among non-Jewish Tay-Sachs disease carriers from the British Isles.
Landels EC; Green PM; Ellis IH; Fensom AH; Bobrow M
J Med Genet; 1992 Aug; 29(8):563-7. PubMed ID: 1387685
[TBL] [Abstract][Full Text] [Related]
36. Mutations of the hexosaminidase A gene in Ashkenazi and non-Ashkenazi Jews.
Peleg L; Karpati M; Gazit E; Raas-Rothschild A; Goldman B
Biochem Med Metab Biol; 1994 Jun; 52(1):22-6. PubMed ID: 7917464
[TBL] [Abstract][Full Text] [Related]
37. Biochemical and mutational analyses of HEXA in a cohort of Egyptian patients with infantile Tay-Sachs disease. Expansion of the mutation spectrum.
Ibrahim DMA; Ali OSM; Nasr H; Fateen E; AbdelAleem A
Orphanet J Rare Dis; 2023 Mar; 18(1):52. PubMed ID: 36907859
[TBL] [Abstract][Full Text] [Related]
38. The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada.
Hechtman P; Boulay B; De Braekeleer M; Andermann E; Melançon S; Larochelle J; Prevost C; Kaplan F
Hum Genet; 1992 Dec; 90(4):402-6. PubMed ID: 1483696
[TBL] [Abstract][Full Text] [Related]
39. A new point mutation (G412 to A) at the last nucleotide of exon 3 of hexosaminidase alpha-subunit gene affects splicing.
Ozkara HA; Sandhoff K
Brain Dev; 2003 Apr; 25(3):203-6. PubMed ID: 12689701
[TBL] [Abstract][Full Text] [Related]
40. Introduction of the alpha subunit mutation associated with the B1 variant of Tay-Sachs disease into the beta subunit produces a beta-hexosaminidase B without catalytic activity.
Brown CA; Neote K; Leung A; Gravel RA; Mahuran DJ
J Biol Chem; 1989 Dec; 264(36):21705-10. PubMed ID: 2532211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
